Nancy B Davis Selected Research

Pain (Aches)

1/2004

Phase II trial of PS-341 in patients with renal cell cancer: a University of Chicago phase II consortium study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nancy B Davis Research Topics

Disease

8	Neoplasms (Cancer) 01/2024 - 01/2004
8	Renal Cell Carcinoma (Grawitz Tumor) 08/2022 - 01/2004
3	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 05/2003
3	Fatigue 10/2019 - 01/2004
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2023 - 11/2023
2	Anemia 03/2008 - 01/2004
2	Disease Progression 10/2005 - 01/2004
1	Penile Neoplasms (Penile Cancer) 12/2023
1	Urinary Bladder Neoplasms (Bladder Cancer) 03/2022
1	Necrosis 01/2020
1	Cicatrix (Scar) 01/2020
1	Fibrosis (Cirrhosis) 01/2020
1	Mucositis 10/2019
1	Dehydration (Water Stress) 10/2019
1	Hand-Foot Syndrome 10/2019
1	Myeloid Sarcoma (Chloroma) 09/2008
1	Philadelphia Chromosome 09/2008
1	Dyspnea (Shortness of Breath) 03/2008
1	Hyperglycemia 03/2008
1	Lymphopenia (Lymphocytopenia) 03/2008
1	Urinary Incontinence 02/2007
1	Aggressive Fibromatosis (Desmoid) 01/2006
1	Testicular Germ Cell Tumor 01/2006
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2006
1	Testicular Neoplasms (Testicular Cancer) 01/2006
1	Febrile Neutropenia 01/2004
1	Pain (Aches) 01/2004
1	Thrombocytopenia (Thrombopenia) 01/2004
1	Hemorrhage 01/2004

Drug/Important Bio-Agent (IBA)

3	Immune Checkpoint InhibitorsIBA 12/2023 - 11/2020
3	NivolumabIBA 08/2022 - 01/2020
2	pembrolizumabIBA 01/2024 - 01/2020
2	enfortumab vedotinIBA 11/2023 - 03/2022
2	IpilimumabIBA 08/2022 - 11/2021
1	PlatinumIBA 01/2024
1	sacituzumab govitecanIBA 01/2024
1	olaparibIBA 01/2023
1	cediranib (AZD2171)IBA 01/2023
1	Immunoconjugates (Immunoconjugate)IBA 03/2022
1	Biomarkers (Surrogate Marker)IBA 11/2021
1	pazopanib FDA Link 11/2020
1	Axitinib (AG 013736)IBA 10/2019
1	Imatinib Mesylate (Gleevec)FDA Link 09/2008
1	CreatinineIBA 03/2008
1	ispinesibIBA 03/2008
1	Flutamide (Eulexin)FDA LinkGeneric 10/2005
1	Prostate-Specific Antigen (Semenogelase)IBA 10/2005
1	AndrogensIBA 10/2005
1	Androgen Antagonists (Antiandrogens)IBA 10/2005
1	bicalutamide (Casodex)FDA LinkGeneric 10/2005
1	nilutamide (Nilandron)FDA Link 10/2005
1	Proteasome InhibitorsIBA 01/2004
1	Bortezomib (Velcade)FDA Link 01/2004
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2004
1	ElectrolytesIBA 01/2004

Therapy/Procedure

9	Therapeutics 01/2024 - 05/2003
2	Drug Therapy (Chemotherapy) 01/2024 - 01/2006
2	Immunotherapy 11/2021 - 01/2020
2	Nephrectomy 11/2020 - 01/2020
2	Aftercare (After-Treatment) 01/2020 - 10/2019
1	Castration 01/2023
1	Prostatectomy (Retropubic Prostatectomy) 02/2007
1	Lymph Node Excision (Lymph Node Dissection) 01/2006
1	Orchiectomy (Orchidectomy) 01/2006
1	Radiotherapy 10/2005